Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with primary lung cancer, confirmed through a tissue or cell sample test
- People who are receiving combination drug therapy for the first time, with a planned treatment course of at least 4 cycles (the specific drug combination does not matter)
- People aged 18 years or older
- People who are able to use a smartphone
- People whose general physical functioning is rated at a certain level (a score of 2 or lower on a standard medical scale used to measure how much a condition affects daily activity — confirm with trial site)
- People who are aware of their own diagnosis and the medications they are taking
- People who agree to take part in the study voluntarily
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a history of mental illness or who are currently receiving mental health treatment
- People who have been diagnosed with cancer in another part of the body (other than the lung)
- People who show signs of cognitive impairment, based on a short memory and thinking test (specifically, making 3 or more errors on the Short Portable Mental Status Questionnaire)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Feifei Huang, Fujian Medical University
Phone: +86 13763869099
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Change in symptom burden measured by the Symptom Assessment Scale for Intervals of Combination Therapy in Patients with Lung Cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.